Shi J - Search Results

1

High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma.

Qian T, Cui L, Liu Y, Cheng Z, Quan L, Zeng T, Huang W, Dai Y, Chen J, Liu L, Chen J, Pang Y, Wu G, Ye X, Shi J, Fu L, Si C. Qian T, et al. Among authors: shi j. Pharmacogenomics J. 2020 Aug;20(4):563-573. doi: 10.1038/s41397-019-0145-6. Epub 2020 Jan 6. Pharmacogenomics J. 2020. PMID: 31902948

2

High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.

Shi JL, Fu L, Wang WD. Shi JL, et al. Oncotarget. 2015 Mar 10;6(7):5299-309. doi: 10.18632/oncotarget.3024. Oncotarget. 2015. PMID: 25779662 Free PMC article.

3

Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.

Fu L, Shi J, Hu K, Wang J, Wang W, Ke X. Fu L, et al. Among authors: shi j. Oncotarget. 2015 Apr 10;6(10):8144-54. doi: 10.18632/oncotarget.3519. Oncotarget. 2015. PMID: 25924238 Free PMC article.

4

Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.

Shi JL, Fu L, Ang Q, Wang GJ, Zhu J, Wang WD. Shi JL, et al. Oncotarget. 2016 Jan 19;7(3):2585-95. doi: 10.18632/oncotarget.6226. Oncotarget. 2016. PMID: 26506237 Free PMC article.

5

High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia.

Fu L, Fu H, Tian L, Xu K, Hu K, Wang J, Wang J, Jing H, Shi J, Ke X. Fu L, et al. Among authors: shi j. Oncotarget. 2016 Mar 29;7(13):15828-39. doi: 10.18632/oncotarget.7489. Oncotarget. 2016. PMID: 26910834 Free PMC article.

6

High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia.

Fu L, Fu H, Zhou L, Xu K, Pang Y, Hu K, Wang J, Tian L, Liu Y, Wang J, Jing H, Huang W, Ke X, Shi J. Fu L, et al. Among authors: shi j. Sci Rep. 2016 Sep 30;6:34546. doi: 10.1038/srep34546. Sci Rep. 2016. PMID: 27686215 Free PMC article.

7

High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.

Shi J, Fu H, Jia Z, He K, Fu L, Wang W. Shi J, et al. EBioMedicine. 2016 Dec;14:55-64. doi: 10.1016/j.ebiom.2016.11.025. Epub 2016 Nov 22. EBioMedicine. 2016. PMID: 27916548 Free PMC article.

8

Combining retinoic acid and oral arsenic may be potentially the first-line therapy for non-high-risk acute promyelocytic leukemia.

Fu L, Shi J, Liu J, Liu A, Xu K, Ke X. Fu L, et al. Among authors: shi j. Stem Cell Investig. 2016 Dec 19;3:93. doi: 10.21037/sci.2016.11.13. eCollection 2016. Stem Cell Investig. 2016. PMID: 28078273 Free PMC article. No abstract available.

9

High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia.

Fu L, Fu H, Qiao J, Pang Y, Xu K, Zhou L, Wu Q, Li Z, Ke X, Xu K, Shi J. Fu L, et al. Among authors: shi j. Cancer Sci. 2017 Sep;108(9):1850-1857. doi: 10.1111/cas.13311. Epub 2017 Aug 20. Cancer Sci. 2017. PMID: 28670859 Free PMC article.

10

High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions.

Fu L, Fu H, Wu Q, Pang Y, Xu K, Zhou L, Qiao J, Ke X, Xu K, Shi J. Fu L, et al. Among authors: shi j. J Transl Med. 2017 Jul 19;15(1):159. doi: 10.1186/s12967-017-1260-2. J Transl Med. 2017. PMID: 28724426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,731 results

Search Page

Filters